UPDATED May 20, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADX | €1.93 | 2.6% | 66.8% | €847.3m | €2.00 | PE19.7x | E25.6% | 0% | Utilities | ||
PHM | €35.94 | 5.3% | 0.3% | €634.0m | €49.20 | PE312.9x | E47.7% | 1.8% | Pharmaceuticals & Biotech | ||
SQRL | €1.59 | 1.0% | -31.7% | €141.1m | n/a | PE10x | E16.1% | n/a | Media | ||
KOM | €0.80 | 0% | 6.7% | €9.6m | €2.00 | PB0.7x | E98.6% | n/a | Materials | ||
ALM | €9.47 | 1.9% | 13.6% | €2.0b | €11.28 | PS2.2x | E48.6% | 2.0% | Pharmaceuticals & Biotech | ||
CASH | €0.54 | 3.5% | -17.9% | €786.8m | n/a | PE11.8x | E23.9% | 4.9% | Commercial Services | ||
LLYC | €9.70 | 2.6% | -11.8% | €109.6m | n/a | PE15x | E17.0% | 1.4% | Media | ||
ACX | €10.39 | 0.1% | 4.4% | €2.6b | €13.77 | PE17.8x | E26.3% | 6.0% | Materials | ||
ART | €4.80 | 0% | 23.1% | €273.4m | €5.22 | PE22.7x | E28.5% | 2.2% | Capital Goods | ||
EDR | €7.07 | 7.0% | 31.9% | €877.6m | €9.01 | PS1.4x | E75.5% | n/a | Consumer Services | ||
ROVI | €87.80 | 3.8% | 104.9% | €4.5b | €89.44 | PE33x | E21.7% | 1.3% | Pharmaceuticals & Biotech | ||
GRF | €9.92 | 1.3% | -15.3% | €6.0b | €16.81 | PE35.7x | E26.5% | n/a | Pharmaceuticals & Biotech | ||
PRS | €0.37 | 0.5% | -6.4% | €368.2m | n/a | PE-20.3x | E73.9% | n/a | Media | ||
APPS | €12.72 | 0.2% | 45.2% | €1.6b | €11.71 | PE62.8x | E32.5% | 1.3% | Commercial Services | ||
IDR | €20.58 | 3.7% | 72.9% | €3.6b | €22.13 | PE16.1x | E12.4% | 1.2% | Software | ||
CLNX | €34.98 | 5.8% | -9.1% | €24.7b | €42.40 | PS6.4x | E69.1% | 0.2% | Telecom |